Crossmark

Pharmacokinetics and safety of vismodegib in patients with advanced solid malignancies and hepatic impairment

Crossref DOI link: https://doi.org/10.1007/s00280-017-3315-8

Published Online: 2017-05-18

Published Print: 2017-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Abou-Alfa, Ghassan K.

Lewis, Lionel D.

LoRusso, Patricia

Maitland, Michael

Chandra, Priya

Cheeti, Sravanthi

Colburn, Dawn

Williams, Sarah

Simmons, Brian

Graham, Richard A.
Funding

Funding for this research was provided by:

Roche
License Information

License valid from 2017-05-18